Paris, France

Antonio Almario

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Almario. Retrieved from https://idiyas.com/inventor/antonio-almario

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Almario: Patent Inventor in Paris

Introduction

Antonio Almario is an inventor associated with Sanofi in Paris, France. His patent work includes a pharmaceutical invention concerning imidazo[1,2-b][1,2,4]triazole derivatives for potential therapeutic use.

Latest Patents

The supplied information lists 1 patent for Almario: “Imidazo[1,2-b][1,2,4]triazol derivatives for use in therapy.” The invention describes compounds of a specified chemical formula, or pharmaceutically acceptable salts, with variations in their substituent groups and aromatic or heteroaromatic structures. It also addresses therapeutic applications, particularly the use of these compounds as anticancer agents.

Career Highlights

Almario is associated with Sanofi, a pharmaceutical company, and his listed patent reflects research into compounds with potential therapeutic applications. The available information does not provide further details about his role, education, or broader career history.

Collaborations

The supplied data names Danielle De Peretti and Amelie Dommergue as Almario’s coworkers. Their specific contributions to the patent or related research are not provided.

Conclusion

Antonio Almario’s listed patent connects his work at Sanofi with research into imidazo[1,2-b][1,2,4]triazole derivatives and their potential use in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…